Business Wire05.08.17
Bovie Medical announced that it has received 510K clearance from the FDA for a new J-Plasma Precise Flex handpiece. The J-Plasma Precise Flex handpiece is designed to be used in robotic-assisted procedures including those with Intuitive Surgical’s da Vinci Surgical System. The J-Plasma Precise Flex includes Bovie Medical’s Cool-Coag technology that combines the unique benefits of J-Plasma, namely increased precision with minimal thermal spread, with standard monopolar coagulation and helium spray coagulation capabilities, all in one handpiece.
The J-Plasma Precise Flex handpiece has a flexible shaft that can be controlled with graspers, forceps or grasping instruments and was designed to be used through an accessory port. When used in robotic-assisted procedures, the J-Plasma Precise Flex can be controlled entirely from a surgeon’s console using a robotic grasper which allows a surgeon the ability to access and visualize a wide variety of surgical planes.
“This new Precise Flex version of J-Plasma offers surgeons the ability to use J-Plasma in areas of the anatomy that otherwise couldn’t be reached with the laparoscopic version,” said Vipul Patel, M.D., Medical Director of Global Robotics Institute at Florida Hospital Celebration Health. “Combining this flexibility with the Cool-Coag technology may also allow the surgeon to complete all aspects of cutting, coagulating and ablating tissue with one instrument potentially reducing the need to use other instruments.”
“The clearance of the J-Plasma Precise Flex is an important milestone for our company as part of our strategy to increase utilization of our innovative technologies in robotic surgery,” said Robert L. Gershon, chief executive officer. “This clearance comes on the heels of the recently announced 510k clearances of both our Cool-Coag generator and our new open handpiece; together, the J-Plasma Precise Flex handpiece and Cool-Coag technology allows surgeons to benefit from using a single device that offers greater control of tissue effect while being able to switch to a monopolar or helium spray coagulation mode from the robotic console. We look forward to a commercial launch of this innovative technology for use in both open and minimally invasive surgical procedures, including laparoscopic and robotic approaches in the second half of 2017.”
The J-Plasma Precise Flex handpiece has a flexible shaft that can be controlled with graspers, forceps or grasping instruments and was designed to be used through an accessory port. When used in robotic-assisted procedures, the J-Plasma Precise Flex can be controlled entirely from a surgeon’s console using a robotic grasper which allows a surgeon the ability to access and visualize a wide variety of surgical planes.
“This new Precise Flex version of J-Plasma offers surgeons the ability to use J-Plasma in areas of the anatomy that otherwise couldn’t be reached with the laparoscopic version,” said Vipul Patel, M.D., Medical Director of Global Robotics Institute at Florida Hospital Celebration Health. “Combining this flexibility with the Cool-Coag technology may also allow the surgeon to complete all aspects of cutting, coagulating and ablating tissue with one instrument potentially reducing the need to use other instruments.”
“The clearance of the J-Plasma Precise Flex is an important milestone for our company as part of our strategy to increase utilization of our innovative technologies in robotic surgery,” said Robert L. Gershon, chief executive officer. “This clearance comes on the heels of the recently announced 510k clearances of both our Cool-Coag generator and our new open handpiece; together, the J-Plasma Precise Flex handpiece and Cool-Coag technology allows surgeons to benefit from using a single device that offers greater control of tissue effect while being able to switch to a monopolar or helium spray coagulation mode from the robotic console. We look forward to a commercial launch of this innovative technology for use in both open and minimally invasive surgical procedures, including laparoscopic and robotic approaches in the second half of 2017.”